Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06319885

Text Messaging to Reduce High-risk Alcohol Use Among Older Adults

High-risk drinking is very prevalent among Danes aged 55+. It poses a serious risk to health and independent living, burdening health care systems and family members. Measures to reduce high-risk alcohol use in this growing group at need are urgently needed. A recent small study from the US shows that text messaging reduces high-risk alcohol intake in older adults. The investigators will conduct a pilot study with the same intervention in Denmark, with adaptations to language and culture. The pilot study will investigate among Danish older adults whether text messaging is well-accepted by participants and feasible in terms of reducing 1) high-risk drinking and 2) commonly accompanying problems with daily functioning, social relationships, and mental and physical health. The pilot-trial will include n=60 adults aged 55-80 years who will receive alcohol-related text messages (within a secure app for data protection purposes) over 12 weeks. Assessments will include a baseline assessment and a post-assessment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

55 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Southern Denmark, Department of Psychology

Odense, Southern Denmark, 5230, Denmark

Location status: Recruiting

Location contact

Silke Behrendt, PhD

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • consumption of > 10 standard drinks á 12 gram ethanol per week (i.e., high-risk alcohol use defined by the Danish Health Authority) in the past four weeks
  • desire to reduce drinking
  • age 55 to 80 years
  • mobile phone ownership and willingness to receive and respond to text messages
  • fluency in Danish.

Exclusion criteria

  • drinking more than 53 standard drinks per week in the last four weeks
  • past 12 month alcohol withdrawal symptoms or lifetime history of serious withdrawal symptoms (e.g., seizures)
  • score above 12 on the Short alcohol withdrawal scale; SAWS
  • possible drug dependence (i.e., use of illegal drugs or psychotropic medication taken without prescription more than once a month)
  • indication of serious psychiatric illness (lifetime diagnosis of psychosis or bipolar disorder, inpatient treatment or medication for these, recent suicidality)
  • current alcohol/drug abuse treatment or a desire to start alcohol/drug abuse treatment during the study
  • medical condition that requires abstinence from alcohol
  • wish to achieve abstinence (applied to secure a focus on reduction)
  • lack of understanding of study protocol or reading difficulty as evidenced by a score of less than 7 out of 10 on the consent form quiz.

Treatment and study plan

Text messaging

Behavioral

Participants receive text messages related to their alcohol consumption.

Primary outcomes

  1. High-risk alcohol use (yes/no)

    Time frame: Assessed at 12 weeks after baseline, alcohol use through the past seven days

    Drinking over 120 gram ethanol in seven days (determined by outcomes 4 & 5 )

Secondary outcomes

  1. WHOQOL-Bref (The World Health Organization Quality of Life Brief Version )

    Time frame: Assessed at 12 weeks after baseline

    Quality of life, functioning. Higher scores represent higher quality of life.

  2. OBSESSIVE-COMPULSIVE DRINKING SCALE (OCDS)

    Time frame: Through the past seven days, assessed at 12 weeks after baseline

    Degree of compulsive alcohol use, with higher scores representing a higher degree

  3. Drinker Inventory of Consequences (DrInC-2R)

    Time frame: Through the past 14 days, assessed at 12 weeks after baseline

    Consequences of drinking, a higher score represents greater consequences

  4. Frequency of alcohol use

    Time frame: Assessed at 12 weeks after baseline, alcohol use through the past seven days

    Measured in number of days

  5. Amount of alcohol use

    Time frame: Assessed at 12 weeks after baseline, alcohol use through the past seven days

    Measured in standard drinks with one drink equivalent to 12 gram pure ethanol

  6. Heavy drinking days

    Time frame: Assessed at 12 weeks after baseline, alcohol use through the past seven days

    Count, number of days with 5 or more standard drinks

  7. User evaluation (tailor-made)

    Time frame: Assessed at 12 weeks after baseline, through 12 weeks (the intervention period)

    Subjective evaluation of user-friendliness, quality of the messages, and cultural adaptation (participants rate the intervention on a scale from 0= do not agree at all through 6= fully agree). Participants also tick off boxes for simple questions on other help received in the study period and on their impressions of the language and cultural appropriateness.

  8. PHQ-9 (Patient Health Questionnaire-9 )

    Time frame: Assessed at 12 weeks after baseline, through the past 14 days

    A higher score represents a greater degree of depressive symptoms

Study contacts

Contact information is provided by the study sponsor or research team.

Anette S Nielsen, PhD

CONTACT

[email protected]

0045 29 13 58 25

Silke Behrendt, PhD

CONTACT

[email protected]

+4593507195

Sponsors and collaborators

Lead sponsor

University of Southern Denmark

Other

Collaborators

  • Alexis Kuerbis
  • Anette Søgaard Nielsen, PhD
  • Angelina Mellentin, PhD
  • Kjeld Andersen, PhD

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 20, 2024
Registry last updated
Apr 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.